ChromaDex Renames External Research Initiative to Niagen Research Program

Niagen Bioscience announced on Tuesday that it has renamed its external research initiative from the ChromaDex External Research Program to the Niagen Research Program. The company stated that this rebranding effort aligns the program’s name with its primary focus on NAD+ science and its ongoing commitment to supporting independent clinical and preclinical studies.

The Niagen Research Program provides researchers with access to the company’s proprietary nicotinamide riboside (NR) ingredient for use in various scientific investigations. By centralizing the program under the Niagen brand, the company aims to streamline its outreach to the global scientific community. The initiative currently maintains a portfolio of collaborative studies that examine the biological effects and potential applications of NAD+ precursors. This transition follows the company’s broader efforts to consolidate its research operations and standardize its scientific communications under a single corporate identity.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: June 2, 2026

Author

GOAI